| 1988 |
Delmas PD. Biochemical markers of bone turnover in osteoporosis. In: Riggs BL, Melton LJ III, eds. Osteoporosis: Etiology, Diagnosis, and Management. New York, NY: Raven Press; 1988:297-316. |
0 |
0 |
| 2003 |
Delmas PD, Genant HK, Crans GG, Stock JL, Wong M, Siris E, Adachi JD. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone. October 2003;33(4):522-532. |
29 |
24 |
| 2004 |
Kanis J, Johnell O, De Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey E, Mellstrom D, Melton L, Pols H, Reeve J, Silman A, Tenenhouse A. A meta-analysis of previous fracture and subsequent fracture risk. Bone. August 2004;35(2):375-382. |
69 |
44 |
| 2006 |
Garnero P, Borel O, Gineyts E, Duboeuf F, Solberg H, Bouxsein ML, Christiansen C, Delmas PD. Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone. Bone. March 2006;38(3):300-309. |
37 |
35 |
| 2011 |
Sode M, Burghardt AJ, Pialat J-B, Link TM, Majumdar S. Quantitative characterization of subject motion in HR-pQCT images of the distal radius and tibia. Bone. June 1, 2011;48(6):1291-1297. |
29 |
25 |
| 2012 |
Pialat JB, Burghardt AJ, Sode M, Link TM, Majumdar S. Visual grading of motion induced image degradation in high resolution peripheral computed tomography: impact of image quality on measures of bone density and micro-architecture. Bone. January 2012;50(1):111-118. |
53 |
42 |
| 2020 |
Rousseau J-C, Bertholon C, Chapurlat R, Szulc P. Serum periostin is associated with cancer mortality but not cancer risk in older home-dwelling men: a 8-year prospective analysis of the STRAMBO study. Bone. March 2020;132:115184. |
0 |
0 |
| 2020 |
Cottard M, Vignot E, Fontanges E, Merle B, Collet C, Chapurlat R. Genetic testing is useful in adults with limited phenotypes of genetic skeletal conditions. Bone. May 2020;134:115218. |
0 |
0 |
| 2021 |
Sutter T, Duboeuf F, Chapurlat R, Cortet B, Lespessailles E, Roux J-P. DXA body composition corrective factors between Hologic Discovery models to conduct multicenter studies. Bone. January 2021;142:115683. |
1 |
1 |
| 2021 |
Cappelle S, Moreau M, Karmali R, Iconaru L, Baleanu F, Kinnard V, Paesmans M, Rozenberg S, Rubinstein M, Surquin M, Blard P-H, Chapurlat R, Body JJ, Bergmann P. Discriminating value of HR-pQCT for fractures in women with similar FRAX scores: a substudy of the FRISBEE cohort. Bone. February 2021;143:115613. |
3 |
3 |
| 2021 |
Pickering M-E, Ltaief-Boudrigua A, Feurer E, Collet C, Chapurlat R. A new lrp6 variant and camurati-engelmann-like disease. Bone. February 2021;143:115706. |
0 |
0 |
| 2021 |
Chapurlat R, Legrand MA. Bisphosphonates for the treatment of fibrous dysplasia of bone. Bone. February 2021;143:115784. |
1 |
0 |
| 2021 |
Sutter T, Duboeuf F, Chapurlat R, Cortet B, Lespessailles E, Roux J-P. Response to “Utilising DXA for body composition research studies”. Bone. August 2021;149:115992. |
0 |
0 |
| 2022 |
Chapurlat R, Gensburger D, Trolliet C, Rouanet S, Mehsen-Cetre N, Orcel P. Inhibition of IL-6 in the treatment of fibrous dysplasia of bone: the randomized double-blind placebo-controlled TOCIDYS trial. Bone. April 2022;157:116343. |
1 |
1 |
| 2022 |
Sornay-Rendu E, Duboeuf F, Ulivieri FM, Rinaudo L, Chapurlat R. The bone strain index predicts fragility fractures: the OFELY study. Bone. April 2022;157:116348. |
0 |
0 |
| 2023 |
Trojani M, Gensburger D, Bagouet F, Cortet B, Couture G, Marcelli C, Mehsen Cetre N, Breuil V, Chapurlat R. Denosumab use in bone fibrous dysplasia refractory to bisphosphonate: a retrospective multicentric study. Bone. September 2023;174:116819. |
1 |
1 |
| 2020 |
Pickering M-E, Chapurlat R. Where two common conditions of aging meet: osteoarthritis and sarcopenia. Calcif Tiss Int. September 2020;107(3):203-211. |
0 |
0 |
| 2002 |
Boivin G, Meunier PJ. Changes in bone remodeling rate influence the degree of mineralization of bone. Connect Tissue Res. April 2002;43(2-3):535-537. |
28 |
27 |
| 1996 |
Garnero P, Sornay‐Rendu E, Chapuy M, Delmas PD. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res. 1996;11(3):337-349. |
68 |
54 |
| 1996 |
Garnero P, Hausherr E, Chapuy M, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res. October 1996;11(10):1531-1538. |
47 |
39 |
| 1997 |
Arlot ME, Sornay-Rendu E, Garnero P, Vey-Marty B, Delmas PD. Apparent pre- and postmenopausal bone loss evaluated by DXA at different skeletal sites in women: the OFELY cohort. J Bone Miner Res. April 1997;12(4):683-690. |
31 |
14 |
| 1998 |
Bass S, Pearce G, Bradney M, Hendrich E, Delmas PD, Harding A, Seeman E. Exercise before puberty may confer residual benefits in bone density in adulthood: studies in active prepubertal and retired female gymnasts. J Bone Miner Res. March 1998;13(3):500-507. |
32 |
30 |
| 2000 |
Garner P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res. August 2000;15(8):1526-1536. |
37 |
30 |
| 2005 |
Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier PJ, Melton LJ III, O'Neill T, Pols H, Reeve J, Silman A, Tenenhouse A. Predictive value of BMD for hip and other fractures. J Bone Miner Res. July 2005;20(7):1185-1194. |
79 |
59 |
| 2005 |
Sornay-Rendu E, Munoz F, Garnero P, Duboeuf F, Delmas PD. Identification of osteopenic women at high risk of fracture: the OFELY study. J Bone Miner Res. October 2005;20(10):1813-1819. |
28 |
21 |
| 2007 |
Bouxsein ML, Szulc P, Munoz F, Thrall E, Sornay‐Rendu E, Delmas PD. Contribution of trochanteric soft tissues to fall force estimates, the factor of risk, and prediction of hip fracture risk*. J Bone Miner Res. June 2007;22(6):825-831. |
30 |
24 |
| 2010 |
Roux J-P, Wegrzyn J, Arlot ME, Guyen O, Delmas PD, Chapurlat R, Bouxsein ML. Contribution of trabecular and cortical components to biomechanical behavior of human vertebrae: an ex vivo study. J Bone Miner Res. February 2010;25(2):356-361. |
17 |
15 |
| 2010 |
Bacchetta J, Boutroy S, Vilayphiou N, Juillard L, Guebre-Egziabher F, Rognant N, Sornay-Rendu E, Szulc P, Laville M, Delmas PD, Fouque D, Chapurlat R. Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney disease. J Bone Miner Res. April 2010;25(4):849-857. |
13 |
11 |
| 2010 |
Wegrzyn J, Roux J, Arlot ME, Boutroy S, Vilayphiou N, Guyen O, Delmas PD, Chapurlat R, Bouxsein ML. Role of trabecular microarchitecture and its heterogeneity parameters in the mechanical behavior of ex vivo human L3 vertebrae. J Bone Miner Res. November 2010;25(11):2324-2331. |
20 |
17 |
| 2016 |
McCloskey EV, Odén A, Harvey NC, Leslie WD, Hans D, Johansson H, Barkmann R, Boutroy S, Brown J, Chapurlat R, Elders PJM, Fujita Y, Glüer C-C, Goltzman D, Iki M, Karlsson M, Kindmark A, Kotowicz M, Kurumatani N, Kwok T, Lamy O, Leung J, Lippuner K, Ljunggren Ö, Lorentzon M, Mellström D, Merlijn T, Oei L, Ohlsson C, Pasco JA, Rivadeneira F, Rosengren B, Sornay-Rendu E, Szulc P, Tamaki J, Kanis JA. A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX. J Bone Miner Res. May 2016;31(5):940-948. |
35 |
21 |
| 2020 |
Legrand MA, Millet M, Merle B, Rousseau J, Hemmendinger A, Gineyts E, Sornay‐Rendu E, Szulc P, Borel O, Croset M, Chapurlat R. A signature of circulating miRNAs associated with fibrous dysplasia of bone: the mirDys study. J Bone Miner Res. October 2020;35(10):1881-1892. |
2 |
1 |
| 2021 |
Szulc P, Foesser D, Chapurlat R. High cardiovascular risk in older men with poor bone microarchitecture: the prospective STRAMBO study. J Bone Miner Res. May 2021;36(5):879-891. |
1 |
1 |
| 2022 |
Whittier DE, Samelson EJ, Hannan MT, Burt LA, Hanley DA, Biver E, Szulc P, Sornay-Rendu E, Merle B, Chapurlat R, Lespessailles E, Wong AKO, Goltzman D, Khosla S, Ferrari S, Bouxsein ML, Kiel DP, Boyd SK. Bone microarchitecture phenotypes identified in older adults are associated with different levels of osteoporotic fracture risk. J Bone Miner Res. March 2022;37(3):428-439. |
6 |
3 |
| 2022 |
Bobillier A, Wagner P, Whittier DE, Ecochard R, Boyd SK, Chapurlat R, Szulc P. Association of vitamin D and parathyroid hormone status with the aging-related decline of bone microarchitecture in older men: the Prospective Structure of Aging Men's Bones (STRAMBO) study. J Bone Miner Res. October 2022;37(10):1903-1914. |
0 |
0 |
| 2023 |
Gunsing E, Wagner PP, Whittier DE, Boyd SK, Chapurlat R, Szulc P. Rapid cortical bone loss at the distal radius is associated with higher risk of fracture in older men: the STRAMBO study. J Bone Miner Res. June 2023;38(6):841-850. |
0 |
0 |
| 2023 |
Whittier DE, Samelson EJ, Hannan MT, Burt LA, Hanley DA, Biver E, Szulc P, Sornay-Rendu E, Merle B, Chapurlat R, Lespessailles E, Wong AKO, Goltzman D, Khosla S, Ferrari S, Bouxsein ML, Kiel DP, Boyd SK. A fracture risk assessment tool for high resolution peripheral quantitative computed tomography. J Bone Miner Res. September 2023;38(9):1234-1244. |
1 |
1 |
| 2023 |
Mercier-Guery A, Millet M, Merle B, Collet C, Bagouet F, Borel O, Sornay-Rendu E, Szulc P, Vignot E, Gensburger D, Fontanges E, Croset M, Chapurlat R. Dysregulation of microRNAs in adult osteogenesis imperfecta: the miROI study. J Bone Miner Res. November 2023;38(11):1665-1678. |
0 |
0 |
| 2000 |
Bone HG, Greenspan SL, McKeever C, Bell N, Davidson M, Downs RW, Emkey R, Meunier PJ, Miller SS, Mulloy AL, Recker RR, Weiss SR, Heyden N, Musliner T, Suryawanshi S, Yates AJ, Lombardi A; The Alendronate / Estrogen Study Group. Alendronate and estrogen effects in postmenopausal women with low bone mineral density. J Clin Endocrinol Metab. February 2000;85(2):720-726. |
9 |
7 |
| 2009 |
Schwartz AV, Garnero P, Hillier TA, Sellmeyer DE, Strotmeyer ES, Feingold KR, Resnick HE, Tylavsky FA, Black DM, Cummings SR, Harris TB, Bauer DC; Health, Aging, and Body Composition Study. Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab. July 2009;94(7):2380-2386. |
24 |
21 |
| 2017 |
Bone HG, Wagman RB, Brandi ML, Brown JP, Chapurlat R, Cummings SR, Czerwiński E, Fahrleitner-Pammer A, Kendler DL, Lippuner K, Reginster J-Y, Roux C, Malouf J, Bradley MN, Daizadeh NS, Wang A, Dakin P, Pannacciulli N, Dempster DW, Papapoulos S. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol. July 2017;5(7):513-523. |
47 |
35 |
| 2017 |
Eastell R, Szulc P. Use of bone turnover markers in postmenopausal osteoporosis. Lancet Diabetes Endocrinol. November 2017;5(11):908-923. |
16 |
13 |
| 2019 |
Samelson EJ, Broe KE, Xu H, Yang L, Boyd S, Biver E, Szulc P, Adachi J, Amin S, Atkinson E, Berger C, Burt L, Chapurlat R, Chevalley T, Ferrari S, Goltzman D, Hanley DA, Hannan MT, Khosla S, Liu C-T, Lorentzon M, Mellstrom D, Merle B, Nethander M, Rizzoli R, Sornay-Rendu E, Van Rietbergen B, Sundh D, Wong AKO, Ohlsson C, Demissie S, Kiel DP, Bouxsein ML. Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study. Lancet Diabetes Endocrinol. January 2019;7(1):34-43. |
64 |
34 |
| 1997 |
Mitton D, Rumelhart C, Hans D, Meunier PJ. The effects of density and test conditions on measured compression and shear strength of cancellous bone from the lumbar vertebrae of ewes. Med Eng Phys. 1997;19(5):464-474. |
22 |
18 |
| 2014 |
Christen P, Ito K, Ellouz R, Boutroy S, Sornay-Rendu E, Chapurlat RD, van Rietbergen B. Bone remodelling in humans is load-driven but not lazy. Nat Commun. September 2014;5:4855. |
36 |
32 |
| 1992 |
Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, Delmas PD, Meunier PJ. Vitamin D₃ and calcium to prevent hip fractures in elderly women. NEJM. December 3, 1992;327(23):1637-1642. |
43 |
39 |
| 2001 |
McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Wasnich RD, Greenwald M, Kaufman J-M, Chesnut CH, Reginster J-Y; Hip Intervention Program Study Group. Effect of risedronate on the risk of hip fracture in elderly women: Hip Intervention Program Study Group. NEJM. February 1, 2001;344(5):333-340. |
71 |
54 |
| 1998 |
Schott AM, Cormier C, Hans D, Favier F, Hausherr E, Dargent-Molina P, Delmas PD, Ribot C, Sebert JL, Breart G, Meunier PJ; EPIDOS Group. How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS prospective study. Osteoporos Int. May 1998;8(3):247-254. |
20 |
17 |
| 2006 |
Viguet-Carrin S, Garnero P, Delmas PD. The role of collagen in bone strength. Osteoporos Int. March 2006;17(3):319-336. |
109 |
103 |
| 2012 |
Rizzoli R, Chapurlat RD, Laroche J-M, Krieg MA, Thomas T, Frieling I, Boutroy S, Laib A, Bock O, Felsenberg D. Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Osteoporos Int. January 2012;23(1):305-315. |
12 |
11 |
| 2020 |
Martin J, Viprey M, Castagne B, Merle B, Giroudon C, Chapurlat R, Schott A-M. Interventions to improve osteoporosis care: a systematic review and meta-analysis. Osteoporos Int. March 2020;31(3):429-446. |
0 |
0 |
| 2020 |
Whittier DE, Boyd SK, Burghardt AJ, Paccou J, Ghasem-Zadeh A, Chapurlat R, Engelke K, Bouxsein ML. Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography. Osteoporos Int. September 2020;31(9):1607-1627. |
53 |
33 |
| 2020 |
Lespessailles E, Chapurlat R. High fracture risk patients with glucocorticoid-induced osteoporosis should get an anabolic treatment first. Osteoporos Int. October 2020;31(10):1829-1834. |
0 |
0 |
| 2021 |
Binkley N, Orwoll E, Chapurlat R, Langdahl BL, Scott BB, Giezek H, Santora AC. Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis. Osteoporos Int. January 2021;32(1):173-184. |
0 |
0 |